Markets › United States › NAS › DERM

Journey Medical Corp

NAS:DERMHealthcareNASDAQ:NCXnasdaq_composite

$4.95−2.75%LiveIn session · ≈ AED 18.18 · Market cap $139.71M · Next earnings Wed 11 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	67.2%	49.2%	58.2%	66.3%	62.8%	59.3%	—	—
Operating margin	17.6%	−55.2%	−37.4%	−2.6%	−24.4%	−13.2%	−13.2%	+0.0 pts
Net margin	11.9%	−69.7%	−40.2%	−4.9%	−26.1%	−18.5%	−18.5%	+0.0 pts
EBITDA margin	20.8%	−51.9%	−31.5%	2.4%	−15.0%	−5.4%	—	—
Return on equity	51.3%	−104.6%	−174.5%	−18.9%	−73.1%	−35.9%	−35.9%	+0.0 pts
Return on assets	10.2%	−45.2%	−28.2%	−5.0%	−18.3%	−12.1%	−12.1%	+0.0 pts
Return on capital employed	32.9%	−76.4%	−71.8%	−5.9%	−30.3%	−14.3%	—	—
Debt / equity	1.0×	0.0×	1.4×	0.9×	1.3×	0.8×	0.8×	+0.0%
Debt / assets	19.1%	0.9%	21.8%	23.1%	32.0%	26.8%	—	—
Interest coverage	11.2×	−5.0×	−13.6×	−1.2×	−5.1×	−2.2×	—	—
Current ratio	1.3×	1.6×	1.2×	1.3×	1.4×	1.8×	1.8×	+0.0%
Quick ratio	1.2×	1.4×	1.0×	1.1×	1.0×	1.5×	—	—
Cash ratio	0.3×	1.0×	0.5×	0.7×	0.6×	0.6×	0.6×	+0.0%
Asset turnover	0.9×	0.6×	0.7×	1.0×	0.7×	0.7×	—	—
Inventory turnover	10.4×	3.3×	2.2×	2.6×	1.4×	2.6×	—	—
Receivables turnover	1.9×	2.7×	2.6×	5.2×	5.5×	2.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—